Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA

Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023­–September 2024. Of 995 M. pneumoniae–positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Amy L. Leber, Tori Embry, Kathy Everhart, Jeanette Taveras, Sophonie J. Oyeniran, Huanyu Wang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Centers for Disease Control and Prevention 2025-03-01
Saila:Emerging Infectious Diseases
Gaiak:
Mycoplasma pneumoniae
COVID-19
respiratory infections
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
SARS
Sarrera elektronikoa:https://wwwnc.cdc.gov/eid/article/31/3/24-1570_article
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak